Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,760.00
-40.00 (-0.59%)
Last updated: Apr 29, 2026, 2:19 PM KST

Kyongbo Pharmaceutical Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
7,2284,1284,4776,3484,290
Upgrade
Short-Term Investments
8202,000870870-
Upgrade
Cash & Short-Term Investments
8,0486,1285,3477,2184,290
Upgrade
Cash Growth
31.34%14.60%-25.92%68.25%-79.55%
Upgrade
Accounts Receivable
63,26851,62456,16050,20246,906
Upgrade
Other Receivables
1,392686.7697.94597.63988.69
Upgrade
Receivables
64,66052,31156,85850,79947,895
Upgrade
Inventory
80,97790,58570,66457,44357,670
Upgrade
Prepaid Expenses
694.321,3111,610115.43913.7
Upgrade
Other Current Assets
4,7581,6061,423749.74397.53
Upgrade
Total Current Assets
159,138151,941135,902116,326111,166
Upgrade
Property, Plant & Equipment
128,02399,85296,07393,91995,677
Upgrade
Long-Term Investments
10,20211,12113,67611,93514,384
Upgrade
Other Intangible Assets
3,8804,0083,6413,2213,355
Upgrade
Long-Term Deferred Tax Assets
13,58713,56513,20311,95110,179
Upgrade
Other Long-Term Assets
4,7083,3993,8103,1942,218
Upgrade
Total Assets
319,538283,887266,305240,545236,979
Upgrade
Accounts Payable
14,77114,95122,77514,74216,404
Upgrade
Accrued Expenses
4,1023,5373,3982,7932,553
Upgrade
Short-Term Debt
101,32189,27173,09563,90055,234
Upgrade
Current Portion of Long-Term Debt
-45909090
Upgrade
Current Portion of Leases
1,0101,0741,078280.59787.02
Upgrade
Current Income Taxes Payable
-86.85118.34166.28-
Upgrade
Other Current Liabilities
26,04523,69517,70713,59613,746
Upgrade
Total Current Liabilities
147,249132,660118,26195,56988,814
Upgrade
Long-Term Debt
24,000-45135225
Upgrade
Long-Term Leases
340.271,0431,629106.58250.75
Upgrade
Pension & Post-Retirement Benefits
114.831,482--927.43
Upgrade
Other Long-Term Liabilities
2,0962,5481,9881,0301,061
Upgrade
Total Liabilities
173,800137,733121,92496,84191,278
Upgrade
Common Stock
11,95311,95311,95311,95311,953
Upgrade
Additional Paid-In Capital
40,06740,06740,06740,06740,067
Upgrade
Retained Earnings
98,12598,33396,03394,69594,587
Upgrade
Comprehensive Income & Other
-4,408-4,199-3,672-3,012-907.41
Upgrade
Shareholders' Equity
145,738146,154144,381143,704145,701
Upgrade
Total Liabilities & Equity
319,538283,887266,305240,545236,979
Upgrade
Total Debt
126,67191,43375,93664,51256,587
Upgrade
Net Cash (Debt)
-118,623-85,305-70,589-57,294-52,296
Upgrade
Net Cash Per Share
-5205.77-3567.15-2952.68-2439.66-2190.88
Upgrade
Filing Date Shares Outstanding
19.4323.9123.9123.9123.91
Upgrade
Total Common Shares Outstanding
19.4323.9123.9123.9123.91
Upgrade
Working Capital
11,88919,28117,64120,75722,352
Upgrade
Book Value Per Share
7501.926113.486039.336011.006094.52
Upgrade
Tangible Book Value
141,858142,146140,741140,483142,346
Upgrade
Tangible Book Value Per Share
7302.195945.845887.055876.265954.19
Upgrade
Land
30,14630,14628,63327,56923,874
Upgrade
Buildings
92,72582,77981,33679,34176,851
Upgrade
Machinery
136,978125,238119,358113,325111,022
Upgrade
Construction In Progress
24,8507,9591,8561,4441,729
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.